2965

antibody from Cell Signaling Technology, Inc

Targeting: AKT1 AKT, PKB, PRKBA, RAC, RAC-alpha

Western blot (Data presented on provider website)

Antibody Data

Product number

2965

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#2965, RRID:AB_2255933

Product name

Phospho-Akt (Thr308) (C31E5E) Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse, Rat, Hamster, Simian

Host

Rabbit

Storage

-20°C

References

Submitted references

AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.

Jothi M, Nishijo K, Keller C, Mal AK
Cell cycle (Georgetown, Tex.) 2012 Mar 1;11(5):895-908

---

AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.

Sykes SM, Lane SW, Bullinger L, Kalaitzidis D, Yusuf R, Saez B, Ferraro F, Mercier F, Singh H, Brumme KM, Acharya SS, Scholl C, Tothova Z, Attar EC, Fröhling S, DePinho RA, Armstrong SA, Gilliland DG, Scadden DT
Cell 2011 Sep 2;146(5):697-708

---

Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.

Mahajan K, Coppola D, Challa S, Fang B, Chen YA, Zhu W, Lopez AS, Koomen J, Engelman RW, Rivera C, Muraoka-Cook RS, Cheng JQ, Schönbrunn E, Sebti SM, Earp HS, Mahajan NP
PloS one 2010 Mar 19;5(3):e9646

---

mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.

Guertin DA, Stevens DM, Saitoh M, Kinkel S, Crosby K, Sheen JH, Mullholland DJ, Magnuson MA, Wu H, Sabatini DM
Cancer cell 2009 Feb 3;15(2):148-59